https://stock.noler.com/us/stock/applied-therapeutics-inc https://stock.noler.com/us/stock/applied-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/applied-therapeutics-inc/accrued-employee-benefits-current https://stock.noler.com/us/stock/applied-therapeutics-inc/accrued-insurance-current https://stock.noler.com/us/stock/applied-therapeutics-inc/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/applied-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/applied-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/applied-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/applied-therapeutics-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/applied-therapeutics-inc/aoci https://stock.noler.com/us/stock/applied-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/applied-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-loss-before-tax https://stock.noler.com/us/stock/applied-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/applied-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/applied-therapeutics-inc/available-for-sale-debt-maturities-next-rolling-twelve-months-amortized-cost-basis https://stock.noler.com/us/stock/applied-therapeutics-inc/available-for-sale-debt-maturities-next-rolling-twelve-months-fair-value https://stock.noler.com/us/stock/applied-therapeutics-inc/available-for-sale-debt-realized-gain https://stock.noler.com/us/stock/applied-therapeutics-inc/available-for-sale-debt-realized-loss https://stock.noler.com/us/stock/applied-therapeutics-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/applied-therapeutics-inc/available-for-sale-debt-unrealized-loss-position https://stock.noler.com/us/stock/applied-therapeutics-inc/available-for-sale-debt-unrealized-loss-position-12-months-or-longer https://stock.noler.com/us/stock/applied-therapeutics-inc/available-for-sale-debt-unrealized-loss-position-12-months-or-longer-loss https://stock.noler.com/us/stock/applied-therapeutics-inc/available-for-sale-debt-unrealized-loss-position-less-than-12-months https://stock.noler.com/us/stock/applied-therapeutics-inc/available-for-sale-debt-unrealized-loss-position-less-than-12-months-loss https://stock.noler.com/us/stock/applied-therapeutics-inc/available-for-sale-debt-unrealized-loss-position-loss https://stock.noler.com/us/stock/applied-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/applied-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/applied-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/applied-therapeutics-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/applied-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/applied-therapeutics-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/applied-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/applied-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/applied-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/applied-therapeutics-inc/contract-liability https://stock.noler.com/us/stock/applied-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/applied-therapeutics-inc/current-assets https://stock.noler.com/us/stock/applied-therapeutics-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/applied-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/applied-therapeutics-inc/debt-carrying-amount https://stock.noler.com/us/stock/applied-therapeutics-inc/deferred-costs-current https://stock.noler.com/us/stock/applied-therapeutics-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/applied-therapeutics-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/applied-therapeutics-inc/deferred-offering-costs https://stock.noler.com/us/stock/applied-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/applied-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/applied-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/applied-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/applied-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-not-subject-to-expiration https://stock.noler.com/us/stock/applied-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/applied-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/applied-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/applied-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/applied-therapeutics-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/applied-therapeutics-inc/derivative-liabilities https://stock.noler.com/us/stock/applied-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/applied-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/applied-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/applied-therapeutics-inc/eps https://stock.noler.com/us/stock/applied-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/applied-therapeutics-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/applied-therapeutics-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/applied-therapeutics-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/applied-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/applied-therapeutics-inc/form-d-other https://stock.noler.com/us/stock/applied-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/applied-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/applied-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/applied-therapeutics-inc/income-tax-examination-penalties-and-interest-accrued https://stock.noler.com/us/stock/applied-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/applied-therapeutics-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/applied-therapeutics-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/applied-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/applied-therapeutics-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/applied-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/applied-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/applied-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/applied-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/applied-therapeutics-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/applied-therapeutics-inc/insurance-settlements-receivable-current https://stock.noler.com/us/stock/applied-therapeutics-inc/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/applied-therapeutics-inc/interest-receivable-current https://stock.noler.com/us/stock/applied-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/applied-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/applied-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/applied-therapeutics-inc/liabilities-noncurrent https://stock.noler.com/us/stock/applied-therapeutics-inc/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/applied-therapeutics-inc/maturities-of-available-for-sale-securities https://stock.noler.com/us/stock/applied-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/applied-therapeutics-inc/net-income https://stock.noler.com/us/stock/applied-therapeutics-inc/net-income-loss-attributable-to-parent-diluted https://stock.noler.com/us/stock/applied-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/applied-therapeutics-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/applied-therapeutics-inc/number-of-operating-segments https://stock.noler.com/us/stock/applied-therapeutics-inc/number-of-reportable-segments https://stock.noler.com/us/stock/applied-therapeutics-inc/oci-available-for-sale-adjustment-before-tax https://stock.noler.com/us/stock/applied-therapeutics-inc/oci-net-of-tax https://stock.noler.com/us/stock/applied-therapeutics-inc/oci-net-of-tax-2 https://stock.noler.com/us/stock/applied-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/applied-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/applied-therapeutics-inc/operating-income https://stock.noler.com/us/stock/applied-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/applied-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/applied-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/applied-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/applied-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/applied-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/applied-therapeutics-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/applied-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/applied-therapeutics-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/applied-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/applied-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/applied-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/applied-therapeutics-inc/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/applied-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/applied-therapeutics-inc/other-current-assets https://stock.noler.com/us/stock/applied-therapeutics-inc/other-current-liabilities https://stock.noler.com/us/stock/applied-therapeutics-inc/other-income https://stock.noler.com/us/stock/applied-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/applied-therapeutics-inc/other-nonoperating-expense https://stock.noler.com/us/stock/applied-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/applied-therapeutics-inc/other-than-temporary-impairment-loss-available-for-sale-debt-recognized-in-earnings https://stock.noler.com/us/stock/applied-therapeutics-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/applied-therapeutics-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/applied-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/applied-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/applied-therapeutics-inc/paid-in-kind-interest https://stock.noler.com/us/stock/applied-therapeutics-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/applied-therapeutics-inc/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/applied-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/applied-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/applied-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/applied-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/applied-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/applied-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/applied-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/applied-therapeutics-inc/prepaid-insurance https://stock.noler.com/us/stock/applied-therapeutics-inc/prepaid-rent https://stock.noler.com/us/stock/applied-therapeutics-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/applied-therapeutics-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/applied-therapeutics-inc/proceeds-from-sale-of-available-for-sale-debt https://stock.noler.com/us/stock/applied-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/applied-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/applied-therapeutics-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/applied-therapeutics-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/applied-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/applied-therapeutics-inc/public-float https://stock.noler.com/us/stock/applied-therapeutics-inc/repayments-of-short-term-debt https://stock.noler.com/us/stock/applied-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/applied-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/applied-therapeutics-inc/revenue https://stock.noler.com/us/stock/applied-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/applied-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/applied-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/applied-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/applied-therapeutics-inc/short-term-investments https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-award-plan-modification-incremental-compensation-cost https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-issued-shares-issued-shares-employee-benefit-plan https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-issued-shares-issued-value-employee-benefit-plan https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/applied-therapeutics-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/applied-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/applied-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/applied-therapeutics-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/applied-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/applied-therapeutics-inc/tax-rate-reconciliation-share-based-compensation-excess-tax-benefit-percent https://stock.noler.com/us/stock/applied-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/applied-therapeutics-inc/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/applied-therapeutics-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/applied-therapeutics-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/applied-therapeutics-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/applied-therapeutics-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/applied-therapeutics-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/applied-therapeutics-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/applied-therapeutics-inc/total-assets https://stock.noler.com/us/stock/applied-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/applied-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/applied-therapeutics-inc/treasury-stock-common-shares https://stock.noler.com/us/stock/applied-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/applied-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/applied-therapeutics-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/applied-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted